These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15246639)

  • 1. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey.
    Lenzen MJ; Scholte op Reimer WJ; Boersma E; Vantrimpont PJ; Follath F; Swedberg K; Cleland J; Komajda M
    Eur Heart J; 2004 Jul; 25(14):1214-20. PubMed ID: 15246639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
    Lipinski MJ; Vetrovec GW; Gorelik D; Froelicher VF
    J Card Fail; 2005 Oct; 11(8):624-30. PubMed ID: 16230267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].
    Macín SM; Perna ER; Címbaro Canella JP; Alvarenga P; Pantich R; Ríos N; Farías EF; Badaracco JR
    Rev Esp Cardiol; 2004 Jan; 57(1):45-52. PubMed ID: 14746717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incident cases of heart failure in a community cohort: importance and outcomes of patients with preserved systolic function.
    Ansari M; Alexander M; Tutar A; Massie BM
    Am Heart J; 2003 Jul; 146(1):115-20. PubMed ID: 12851618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.
    Yancy CW; Lopatin M; Stevenson LW; De Marco T; Fonarow GC;
    J Am Coll Cardiol; 2006 Jan; 47(1):76-84. PubMed ID: 16386668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients with heart failure in clinical practice: differences between men and women.
    Lenzen MJ; Rosengren A; Scholte op Reimer WJ; Follath F; Boersma E; Simoons ML; Cleland JG; Komajda M
    Heart; 2008 Mar; 94(3):e10. PubMed ID: 17575332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia in patients with heart failure and preserved systolic function.
    Felker GM; Shaw LK; Stough WG; O'Connor CM
    Am Heart J; 2006 Feb; 151(2):457-62. PubMed ID: 16442914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical outcome and reversibility of systolic dysfunction in patients with dilated cardiomyopathy due to hypertension and chronic heart failure].
    Anguita Sánchez M; Rodríguez Esteban M; Ojeda Pineda S; Ruiz Ortiz M; Romo Peña E; Mesa Rubio D; Vallés Belsué F
    Rev Esp Cardiol; 2004 Sep; 57(9):834-41. PubMed ID: 15373989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
    Velazquez EJ; Francis GS; Armstrong PW; Aylward PE; Diaz R; O'Connor CM; White HD; Henis M; Rittenhouse LM; Kilaru R; van Gilst W; Ertl G; Maggioni AP; Spac J; Weaver WD; Rouleau JL; McMurray JJ; Pfeffer MA; Califf RM;
    Eur Heart J; 2004 Nov; 25(21):1911-9. PubMed ID: 15522470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of patients with heart failure and preserved left ventricular function.
    Gotsman I; Zwas D; Planer D; Azaz-Livshits T; Admon D; Lotan C; Keren A
    Am J Med; 2008 Nov; 121(11):997-1001. PubMed ID: 18954847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure.
    Ingle L; Rigby AS; Carroll S; Butterly R; King RF; Cooke CB; Cleland JG; Clark AL
    Eur Heart J; 2007 Mar; 28(5):560-8. PubMed ID: 17314108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of heart failure and left ventricular systolic dysfunction after cardiac pacing in patients with preserved left ventricular systolic function.
    Kachboura S; Ben Halima A; Fersi I; Marrakchi S; Zouaoui W; Kammoun I
    Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):29-36. PubMed ID: 18062936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation in heart failure: high mortality risk even if ventricular function is preserved.
    Parkash R; Maisel WH; Toca FM; Stevenson WG
    Am Heart J; 2005 Oct; 150(4):701-6. PubMed ID: 16209969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.
    Nieminen MS; Brutsaert D; Dickstein K; Drexler H; Follath F; Harjola VP; Hochadel M; Komajda M; Lassus J; Lopez-Sendon JL; Ponikowski P; Tavazzi L; ;
    Eur Heart J; 2006 Nov; 27(22):2725-36. PubMed ID: 17000631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.
    Gheorghiade M; Abraham WT; Albert NM; Gattis Stough W; Greenberg BH; O'Connor CM; She L; Yancy CW; Young J; Fonarow GC;
    Eur Heart J; 2007 Apr; 28(8):980-8. PubMed ID: 17309900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality benefit of a comprehensive heart failure disease management program in indigent patients.
    Hebert KA; Horswell RL; Dy S; Key IJ; Butler MK; Cerise FP; Arcement LM
    Am Heart J; 2006 Feb; 151(2):478-83. PubMed ID: 16442918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect.
    Schubert S; Peters B; Abdul-Khaliq H; Nagdyman N; Lange PE; Ewert P
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):333-7. PubMed ID: 15736252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.